Gain Therapeutics Company
By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding, including lysosomal storage disorders.
%20.jpg)
Industry:
Advanced BioTech R&D
Founded Date:
2017
Employee Number:
28
Headquarters:
Bethesda, Maryland, United States
Funding Status:
Public